Healthy volunteers needed to test safety of experimental drug LY4515100
NCT ID NCT07339722
First seen Jan 20, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This early-stage study tests whether the experimental drug LY4515100 is safe and tolerable in 40 healthy adults. Participants take the drug or a placebo and undergo blood tests and overnight stays over 30 days. The goal is to learn how the body processes the drug, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.